Tumor volume and weight measurements showed that no significant alterations were seen in tumor volume and weight as compared with the Flag-Fbxo22 group with the pCDH group, and compared with the Flag-Fbxo22 group with the Flag-Fbxo22 + HA-KDM5A group (Fig. 6C–E). This evidence concerns the gene FBXO22 and neoplasm.